header image

Invited speakers

Max von Pettenkofer-Institute
Ludwig-Maximilians-University Munich

Medical and Molecular Microbiology Unit
Faculty of Science and Medicine
Director, National Reference Center for Emerging Antibiotic Resistance (Switzerland)
University of Fribourg (Switzerland)

Laurent Poirel is Associate Professor at the “Emerging Resistance to Antibiotics” Research Unit and Director of the Swiss National Reference Center for Emerging Antibiotic Resistance at the University of Fribourg. His research interests emerging mechanisms of resistance to ß-lactams, polymyxins, and quinolones in Gram-negative rods, either in human and veterinary medicine. He is specialized on the genetics of acquisition of antibiotic (ß-lactams, quinolones, polymyxins) resistance genes in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii and discovery of novel antibiotic resistance mechanisms in those species. He is the author of more than 640 publications in international journals, his Google Scholar H-index being 146.

He is the Editor-in-Chief of the European Journal of Clinical Microbiology and Infectious Diseases and Associate Editor of two highly-ranked journals, i.e. Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Agents.

He has co-invented a series of rapid diagnostic tests for detection of emerging resistance traits, including the Carba NP test. In addition, he is co-inventor of a series of 15 patents mainly corresponding to rapid diagnostic tests or antibiotic selective media.

Head Molecular and Experimenta
Mycobacteriology Group
Head Nat. Reference Center for Mycobacteria
Director Priority Area Infections
Schleswig-Holstein Excellence Chair
Visiting Professor University of Namibia
Speaker Leibniz Science Campus EvoLUNG
Research Center Borstel

Prof. Dr. Johannes Krause earned his Ph.D. in Genetics at Leipzig University. He was appointed junior professor for Paleogenetics at the University of Tübingen in 2010, and subsequently full professor for Archaeo- and Paleogenetics at the same university in 2013. In 2014, he became founding director of the Max Planck Institute for the Science of Human History in Jena, heading the Department of Archaeogenetics. In 2018 he became full professor at the Friedrich Schiller University Jena. He is one of the founding directors of the Max Planck-Harvard Research Center for the Archaeoscience of the Ancient Mediterranean (MHAAM), established in 2017. In 2020 he was reappointed to the Max Planck Institute for Evolutionary Anthropology and his department moved to Leipzig.

Prof. Dr. Krause focuses on the analysis of ancient DNA to investigate such topics as pathogens from historic and prehistoric epidemics, human genetic history, and human evolution. He contributed substantially to deciphering the Neanderthal genome and the shared genetic heritage of Neanderthals and modern humans. In 2010, while working at the Max Planck Institute for Evolutionary Anthropology in Leipzig, he discovered the first genetic evidence of the Denisovans, an extinct hominin found in Siberia. His recent work includes revealing the genetic heritage of ancient Egyptians, reconstructing the first Pleistocene African genomes, uncovering the source of the epidemic plague bacteria that periodically caused historic and prehistoric epidemics in Europe, and clarifying the complex history of Europe’s prehistoric mass migrations. Prof. Dr. Krause has more than 250 publications in peer-reviewed journals, including Nature, Science, Cell, Nature Reviews Genetics, PNAS, Nature Microbiology, Nature Communications, etc. He also authored two international bestsellers translated into more than 20 languages.

Clinic Director
Clinic for Anaesthesiology and Intensive Care Medicine
Essen University Hospital (AöR)

Clinical and scientific career
from 10/2022 Deputy Medical Director, Essen University Hospital
from 02/2020 Clinic Director, Clinic for Anaesthesiology & Intensive Care Medicine, Essen University Hospital
from 02/2020 Full Professor of ‘Anaesthesiology & Anaesthesiological Intensive Care Medicine’ at the University of Duisburg-Essen (UDE)
from 07/2018 ‘Associate Professor’ for Anaesthesiology, Ruprecht-Karls-University, Medical Faculty Heidelberg
from 04/2017 Head Senior Physician, Clinic for Anaesthesiology, Heidelberg University Hospital
09/2015 ‘Venia Legendi’ for the subject Anaesthesiology, Ruprecht-Karls-University, Medical Faculty Heidelberg
04/2014 Additional qualification in ‘Special anaesthesiological intensive care medicine’
from 01/2014 Senior Physician, Clinic for Anaesthesiology, Heidelberg University Hospital
07/2013 - 12/2013 Senior consultant, Department of Anaesthesiology, Heidelberg University Hospital
05/2010 Specialist in anaesthesiology
10/2007 Additional qualification in ‘Emergency Medicine’
Since 01/2005 Research assistant, Department of Anaesthesiology, Heidelberg University Hospital

Selected research funding
05/2021 Project funding from the Dietmar Hopp Foundation
Project title: ‘Next-Generation Sequencing diagnostics of bacteremia in Pediatric Sepsis’ (Next GeneSiPS-Trial) (funding amount: € 431,000)
12/2020 Project funding from the Innovation Fund of the G-BA
Project title: ‘Optimisation of sepsis therapy on the basis of patient-specific digital precision diagnostics’ (DigiSep-Trial) (funding volume: €3,171,100)
02/2019 Project funding from the Dietmar Hopp Foundation
Project title: ‘Next-generation sequencing diagnostics of bacteremia in sepsis’ (Next GeneSiS-Trial) (funding volume: €504,692)
09/2017 Grant from the German Research Foundation (DFG)
Project title: ‘Methylglyoxal (MG)-related carbonyl stress in sepsis’ (GZ: BR4154/2-1; funding volume: €251,725)

Selected scientific prizes
06/2024 Science Award of the Stifterverband 2024 - Forschung im Verbund, Fraunhofer Annual Conference, 12 June 2024 / ‘Next-generation diagnostics for pathogen identification in infectious diseases in intensive care medicine’
02/2019 1st place ‘SIK Innovation Award 2019’, 15th Stuttgart Intensive Care Congress, ‘Next Generation Sequencing (NGS)-based pathogen diagnostics in sepsis’

University education
10/2013 - 09/2015 ‘Master of Health Business Administration (MHBA)’, Friedrich-Alexander-University Erlangen-Nuremberg
2001-2005 Doctorate, Faculty of Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg
11/2004 Medical examination & licence to practise medicine
2000-2003 Study of human medicine, Faculty of Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg
1998-2000 Study of human medicine, Ruprecht-Karls-University Heidelberg